Why Your Clinical Data Strategy is Crucial During Study Start-Up

There is a plethora of data points needed to run a successful trial through to approval. Clinical Operations, Drug Supply and Data Management may have different uses for the same data, and therefore the way that they track the data through many different systems varies. This complexity makes it even more important to begin with the end in mind. What data needs to be collected? What is the system of record? Is the terminology consistent? How can you eliminate duplication and gaps in data? This webinar discusses best practices for incorporating your data strategy into the study start-up process to ensure a successful trial close.
Learning Objectives:
- Work backwards to ensure you are incorporating your data story into study start-up
- Discuss data challenges from a variety of perspectives: operational, supply management and data management
- Explore considerations to develop a holistic data strategy across different teams and clinical systems
- Ensure your clinical systems integrations are capturing the right data
Speakers
- Jay Russak, MBA Director of Clinical Development Operations at Dicerna Pharmaceuticals
- Jamini Shah Director of Clinical Operations at Schrödinger
- Rachel Nering Global Head of Early Stage Oncology Clinical Operations at Sanofi
- Carla Reis Senior Client Director at 4G